Last updated:
According to the study of the Center for Global Development, the cost of treatment from antibiotic resistance can be $ 159 billion by 2050. This will have the most impact on low and moderate income countries.
The number of deaths may increase not only due to the effect of antibiotics.Highlights
- The cost of treatment with antibiotic resistance can be $ 159 billion by 2050.
- Antibiotic resistance will have the most impact on low and medium -income countries.
- Deaths by 2050 by 2050 can increase by 60% by antibiotic resistance.
These resistant bacteria are called superbugs which do not allow normal drugs to be affected. This increases the number of patients hospitalized and the duration of treatment and their treatment also becomes more difficult and expensive. According to the study, this problem will be more serious especially in low and medium -income countries, where resources are limited.
The study used data from Institute for Health Metrix and Evolution (IHME), which estimates that by 2050 it is estimated that by 2050, deaths due to antibiotic resistance may increase by 60 per cent. Between 2025 and 2050, 3.85 crore people can be hit.
Researchers led by Fellow Anthony McDonal, the policy of the Center for Global Development, said, “The most affects the antibiotic resistance on low and moderate income countries. It increases the cost of health care and affects the global economy.”
Research suggests that it is necessary to promote new and effective drugs, ensure correct use of antibiotics and increase access to high quality treatment. If deaths due to antibiotic resistance are stopped, then by 2050 the world’s population will be 2.22 crore more. This study explains the need to take immediate steps for governments and health organizations.
